Quick answer
Biomarin Pharmaceutical Inc (BMRN) reported diluted EPS of $0.23 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-06. Its last four 10-Q/10-K filings were on 2026-08-06, 2026-05-05, 2026-02-26, 2025-10-28.
Data as of 2026-08-06. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-06 | $0.23 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-05 | $0.54 |
| 2025-12-31 | Full year | 10-K | 2026-02-26 | $1.80 |
| 2025-09-30 | Quarter | 10-Q | 2025-10-28 | $-0.16 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-05 | $1.23 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-02 | $0.95 |
| 2024-12-31 | Full year | 10-K | 2025-02-24 | $2.21 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $0.55 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-05 | $0.55 |
| 2024-03-31 | Quarter | 10-Q | 2024-04-26 | $0.46 |
| 2023-12-31 | Full year | 10-K | 2024-02-26 | $0.87 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-02 | $0.21 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-02 | $0.29 |
| 2023-03-31 | Quarter | 10-Q | 2023-04-28 | $0.27 |
| 2022-12-31 | Full year | 10-K | 2023-02-27 | $0.75 |
| 2022-09-30 | Quarter | 10-Q | 2022-10-28 | $-0.04 |
Related
- BKNG earnings report dates and EPS history (Booking Holdings Inc.)
- BLK earnings report dates and EPS history (BlackRock, Inc.)
- BMNR earnings report dates and EPS history (Bitmine Immersion Technologies, Inc.)
- BMY earnings report dates and EPS history (Bristol-Myers Squibb Company)
- BNY earnings report dates and EPS history (Bank of New York Mellon Corp)
- BPOP earnings report dates and EPS history (Popular, Inc.)
- BR earnings report dates and EPS history (Broadridge Financial Solutions, Inc.)
- BRKR earnings report dates and EPS history (Bruker Corporation)
Last updated 2026-10-16. Data only, not financial or tax advice.